ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

9,173Medicare Part D Prescriptions Filled, Including Refills
$422K Total Retail Price of All Prescriptions
317 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
AMLODIPINE BESYLATE 479 420
SIMVASTATIN 325 294
LISINOPRIL 281 182
PRAVASTATIN SODIUM 259 197
LEVOTHYROXINE SODIUM 256 174
METOPROLOL TARTRATE 242 168
ALLOPURINOL 228 210
ATENOLOL 207 158
ALENDRONATE SODIUM 204 204
METOPROLOL SUCCINATE 185 162
OMEPRAZOLE 179 146
HYDROCODONE-ACETAMINOPHEN 168 101 S3
LOSARTAN-HYDROCHLOROTHIAZIDE 165 158
NABUMETONE 161 122
LOSARTAN POTASSIUM 160 151
METFORMIN HCL 157 116
ATORVASTATIN CALCIUM 149 103
FUROSEMIDE 148 121
PROAIR HFA 143 98
CRESTOR 128 124
RANITIDINE HCL 125 98
HYDROCHLOROTHIAZIDE 123 81
FLUTICASONE PROPIONATE 118 91
TRAMADOL HCL 103 84
CLOPIDOGREL 98 95
CLONIDINE HCL 97 79
DIOVAN 94 90
POTASSIUM CHLORIDE 94 75
ISOSORBIDE MONONITRATE ER 93 85
PREDNISONE 90 68
GLIPIZIDE 88 65
LOVASTATIN 85 81
MELOXICAM 81 79
PLAVIX 80 72
JANUVIA 76 54
CARVEDILOL 74 62
DONEPEZIL HCL 72 70
ADVAIR DISKUS 71 61
HYDRALAZINE HCL 69 62
GLYBURIDE 69 54 R
LISINOPRIL-HYDROCHLOROTHIAZIDE 67 56
GABAPENTIN 66 52
FAMOTIDINE 65 53
ZOLPIDEM TARTRATE 63 28
BENAZEPRIL HCL 60 54
CIPROFLOXACIN HCL 59 43
AZITHROMYCIN 59 45
PANTOPRAZOLE SODIUM 56 52
CEPHALEXIN 55 40
SPIRONOLACTONE 55 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.